Reagenzien und Instrumente für die Immunologie
Zellbiologie und Molekularbiologie
Anmelden
Kennwort vergessen?
Legen Sie ein Konto an
de
en
0
0
Einkaufswagen
Katalog
Stichworte
Diagnose
Benutzerdefinierte Dienste
CRO services
Technische Ressourcen
Sonderangebote
Kontakt
Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie
Ergebnis Ihrer Suche : 11 Produkt(e) gefunden
Grenzen Sie Ihre Suche ein :
RUO
CE / IVD
Class (1)
Biochemicals
Application (1)
WB
8
FILTER ANWENDEN
REINITIALISIEREN
DIESE SUCHE TEILEN
KOPIED
10
20
50
100
200
500
Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
MBS2086208-0,01mg
OVA conjugated Epidermal Growth Factor (EGF)
0.01mg
MBS2086208-0,2mg
OVA conjugated Epidermal Growth Factor (EGF)
0.2mg
MBS2086208-0,1mg
OVA conjugated Epidermal Growth Factor (EGF)
0.1mg
MBS2086208-1mg
OVA conjugated Epidermal Growth Factor (EGF)
1mg
MBS2086208-0,5mg
OVA conjugated Epidermal Growth Factor (EGF)
0.5mg
MBS2086208-5mg
OVA conjugated Epidermal Growth Factor (EGF)
5mg
MBS2086208-5x5mg
OVA conjugated Epidermal Growth Factor (EGF)
5x5mg
MBS2086208-0,05mg
OVA conjugated Epidermal Growth Factor (EGF)
0.05mg
orb1910500-1g
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
1g
orb1910500-250mg
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
250mg
orb1910500-100mg
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
100mg
‹
›
